St. Francis Cancer Center | St. Francis Cancer Center | Amgen 20150288
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1706
clinical-trial-template-default,single,single-clinical-trial,postid-1706,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.7,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Amgen 20150288

A Phase 2 Open-Label Study Investigating the Safety and Efficacy of Blinatumomab After Frontline R-Chemotherapy in Adult Subjects with Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma (DLBCL). >Read More

« Available Clinical Trials